| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |